Particularly liked this chart which I hadn't seen before. This is only from March data but there were a few patients at that point in time doing really well - 4 were still on trial at Cycle 10 (cycles of gem/nab pacli are 28 days each, so around 280 days in) with good response rates - from 50 to 80% reduction in size of their target lesions.
Add to My Watchlist
What is My Watchlist?
